Contact and Members
The Selection Committee of BioBAC and its members source, select and invest in promising live sciences start-ups. Each member is committed to invest CHF 20′000 or more every year in one or several presenting entrepreneurs. BioBAC started in January 2007 and did attract more than 30 active angel investors the first year.
Board & Selection Committee:
- Peter Burckhardt, PhD, CEO EVA - the Basel life sciences agency (President)
- Fritz R. Bühler, MD, angel, ex Roche R&D, ex VC
- Jürg Geigy, PhD law, investor since 1978, ex VC (NMT)
- Ruedi Gygax, PhD, Nextech Ventures
- Matthias Staehelin, PhD law, VISCHER.com